GlassScriptPhysician profile
Usman Sarwar
NPI 1023490430
$2,371.59
in general payments reported to CMS, 2019-2025
12 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.06 · 2021: $130 · 2022: $93.79 · 2023: $437 · 2024: $1,280 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,134.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $925.98 | 2024-2025 | Optis, Esprit, Amplatzer Amulet |
| Boston Scientific Corporation | $667.47 | 2022-2025 | Sentinel, Stingray, Avvigo Guidance System |
| Angiodynamics, INC. | $217.71 | 2024-2025 | Alphavac, Angiovac |
| Medtronic, INC. | $198.62 | 2021-2023 | Onyx Frontier |
| Heartflow, INC. | $149.02 | 2023 | Ffrct |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Abiomed | $45.64 | 2022 | |
| Surmodics, INC. | $29.44 | 2024 | Sublime Radial Access Guide Sheath, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 035, 200cm, Angle |
| Astrazeneca Pharmaceuticals LP | $20.00 | 2024 | Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.54 | 2022 | |
| Amgen INC. | $15.11 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Sarwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.